阿尔托神经科学 ANRO
$25.16 +$3.29 (+15.04%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $25.03 -0.52%
开盘$22.12
昨收$21.87
当日区间$21.87 – $25.45
成交量617.5K
市值$987.33M
市盈率（TTM）–
股息率–
ANRO 相关新闻
匹配 Alto Neuroscience 或代码 ANRO 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $55
- H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Raises Target Price to $55 正面
- Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alto Neuroscience, Inc. (ANRO) and Irhythm Technologies (IRTC)
- BofA Securities Maintains Alto Neuroscience(ANRO.US) With Buy Rating
- BTIG Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $37
- BTIG Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Raises Target Price to $37 正面
- Alto Neuroscience, Inc. (ANRO) Receives a Buy From Jefferies
- Jefferies Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Raises Target Price to $40 正面
- Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)
- Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), Alto Neuroscience, Inc. (ANRO) and Astrana Health (ASTH)
- BTIG Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $28
- Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)
- JonesTrading Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $44
- H.C. Wainwright Remains a Buy on Alto Neuroscience, Inc. (ANRO)
- H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $50
暂无评论——快来第一个聊聊 ANRO。